These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12914819)

  • 1. Perspectives on complement in xenotransplantation.
    Mollnes TE; Fiane AE
    Mol Immunol; 2003 Sep; 40(2-4):135-43. PubMed ID: 12914819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenotransplantation--state of the art--update 1999.
    Bühler L; Friedman T; Iacomini J; Cooper DK
    Front Biosci; 1999 Apr; 4():D416-32. PubMed ID: 10209058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenotransplantation: how to overcome the complement obstacle?
    Mollnes TE; Fiane AE
    Mol Immunol; 1999; 36(4-5):269-76. PubMed ID: 10403480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives].
    Malassagne B; Calmus Y; Houssin D; Weill B
    Pathol Biol (Paris); 2000 May; 48(4):377-82. PubMed ID: 10868402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunology of xenotransplantation.
    Saadi S; Platt JL
    Life Sci; 1998; 62(5):365-87. PubMed ID: 9449228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of complement in xenotransplantation.
    Mollnes TE; Fiane AE
    Allergy; 2002; 57 Suppl 72():75-8. PubMed ID: 12144560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.
    Lam TT; Hausen B; Hook L; Lau M; Higgins J; Christians U; Jacobsen W; Baluom M; Duthaler R; Katopodis A; Chavez G; Cozzi E; Harrison R; Schuurman HJ; Borie D; Morris RE
    Xenotransplantation; 2005 Jan; 12(1):20-9. PubMed ID: 15598270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor.
    Dalmasso AP; Platt JL
    Transplantation; 1993 Nov; 56(5):1171-6. PubMed ID: 8249120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenotransplantation--state of the art.
    Cooper DK
    Front Biosci; 1996 Sep; 1():d248-65. PubMed ID: 9159232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A murine model of antibody-mediated hyperacute rejection by galactose-alpha(1,3)galactose antibodies in Gal o/o mice.
    McKenzie IF; Li YQ; Patton K; Thall AD; Sandrin MS
    Transplantation; 1998 Sep; 66(6):754-63. PubMed ID: 9771839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide.
    Ashton-Chess J; Meurette G; Karam G; Petzold T; Minault D; Naulet J; Tesson L; Plat M; Anegon I; Soulillou JP; Blancho G
    Xenotransplantation; 2004 Mar; 11(2):112-22. PubMed ID: 14962273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reaction of complement with endothelial cells in a model of xenotransplantation.
    Dalmasso AP; Platt JL; Bach FH
    Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):31-5. PubMed ID: 1718641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse-to-rabbit xenotransplantation: a new small animal model of hyperacute rejection mediated by the classical complement pathway.
    Kerr SR; Dalmasso AP; Apasova EV; Chen SS; Kirschfink M; Matas AJ
    Transplantation; 1999 Feb; 67(3):360-5. PubMed ID: 10030279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pig to canine auxiliary hepatic xenotransplantation model: prevention of hyperacute rejection via Kupffer cell blockade and complement regulation.
    Chung KY; Park JJ; Han KH
    Transplant Proc; 2008 Oct; 40(8):2755-9. PubMed ID: 18929854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional activity of the membrane-associated complement inhibitor CD59 in a pig-to-human in vitro model for hyperacute xenograft rejection.
    Heckl-Ostreicher B; Binder R; Kirschfink M
    Clin Exp Immunol; 1995 Dec; 102(3):589-95. PubMed ID: 8536377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspects of the Complement System in New Era of Xenotransplantation.
    Miyagawa S; Maeda A; Toyama C; Kogata S; Okamatsu C; Yamamoto R; Masahata K; Kamiyama M; Eguchi H; Watanabe M; Nagashima H; Ikawa M; Matsunami K; Okuyama H
    Front Immunol; 2022; 13():860165. PubMed ID: 35493484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation.
    Oriol R; Ye Y; Koren E; Cooper DK
    Transplantation; 1993 Dec; 56(6):1433-42. PubMed ID: 8279016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xenotransplantation: state of the art.
    Lavitrano M; Frati L
    Forum (Genova); 1999; 9(3 Suppl 3):74-83. PubMed ID: 10607850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of the early xenograft response: from hyperacute rejection to delayed xenograft injury.
    Ierino FL; Sandrin MS
    Crit Rev Immunol; 2007; 27(2):153-66. PubMed ID: 17725501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intervention strategies and agents mediating the prevention of xenorejection.
    Ghebremariam YT; Smith SA; Anderson JB; Kahn D; Kotwal GJ
    Ann N Y Acad Sci; 2005 Nov; 1056():123-43. PubMed ID: 16387682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.